Recombinant Rubella Virus spike glycoprotein E1 protein (Fc Chimera)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Rubella Virus spike glycoprotein E1 protein (Fc Chimera) is a Rubella virus strain Therien Fragment protein, in the 583 to 1025 aa range, expressed in HEK 293 cells, with >95%, suitable for SDS-PAGE, FuncS.
View Alternative Names
Structural polyprotein, p110
- FuncS
Supplier Data
Functional Studies - Recombinant Rubella Virus spike glycoprotein E1 protein (Fc Chimera) (AB256429)
Detection of anti-Rubella IgG in human serum.
Plate coated with 50 ng/well of antigens. E1 = ab256429
Antigens coated in bicarbonate-carbonate buffer pH 9.6 for 1 hour at RT. Blocked with 2% BSA/PBS for 2 hours at RT.
Washed x3 with Tris washing buffer.
Serum samples (Public Health England) diluted 1/201 in 1% BSA in PBS-T.
Secondary antibody was anti-Human-IgG-HRP diluted 1/10000 in 1% BSA in PBS-T. TMB detection.
- FuncS
Supplier Data
Functional Studies - Recombinant Rubella Virus spike glycoprotein E1 protein (Fc Chimera) (AB256429)
Detection of anti-Rubella IgM in human serum.
Plate coated with 100 ng/well of antigens. E1 = ab256429
Washed x3 with Tris washing buffer.
Serum samples (Public Health England) diluted 1/201 in 1% BSA in PBS-T + 4% IgG/RF stripper. After standing for 30 minutes the diluted samples were centrifuged at 17,000 x g for 1 minute and the supernatant used for ELISA.
Secondary antibody was anti-Human-IgM-HRP diluted 1/10000 in 1% BSA in PBS-T. TMB detection.
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Rubella Virus spike glycoprotein E1 protein (Fc Chimera) (AB256429)
SDS-PAGE analysis of 3.2 μg (Lane 1) and 1.7 μg (Lane 2) of ab256429 under reducing conditions.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The E1 protein contributes to the formation of the rubella virus envelope complex working in tandem with another glycoprotein called E2. This complex is essential for virion assembly and maturation. The interaction between E1 and E2 is necessary for maintaining structural integrity and for ensuring the infectivity of the rubella virus. The envelope complex also plays a role in the immune evasion strategies of the virus helping it to avoid host immune surveillance.
Pathways
The E1 protein's role in viral entry places it within the endocytic and membrane fusion pathways. These processes are important for host-pathogen interactions and involve coordination with cellular proteins like clathrin and dynamin. Additionally E1 works in conjunction with proteins involved in the cellular response to virus infection including interferon-induced antiviral effectors. Its interaction with these pathways highlights its importance in ensuring successful establishment and spread of infection within host tissues.
Specifications
Form
Liquid
Additional notes
Buffered in DPBS, pH7.4.
General info
Function
Capsid protein. Capsid protein interacts with genomic RNA and assembles into icosahedric core particles 65-70 nm in diameter. The resulting nucleocapsid eventually associates with the cytoplasmic domain of E2 at the cell membrane, leading to budding and formation of mature virions from host Golgi membranes. Phosphorylation negatively regulates RNA-binding activity, possibly delaying virion assembly during the viral replication phase. Capsid protein dimerizes and becomes disulfide-linked in the virion. Modulates genomic RNA replication. Modulates subgenomic RNA synthesis by interacting with human C1QBP/SF2P32. Induces both perinuclear clustering of mitochondria and the formation of electron-dense intermitochondrial plaques, both hallmarks of rubella virus infected cells. Induces apoptosis when expressed in transfected cells.. Spike glycoprotein E2. Responsible for viral attachment to target host cell, by binding to the cell receptor. Its transport to the plasma membrane depends on interaction with E1 protein. The surface glycoproteins display an irregular helical organization and a pseudo-tetrameric inner nucleocapsid arrangement.. Spike glycoprotein E1. Class II viral fusion protein (By similarity). Fusion activity is inactive as long as E1 is bound to E2 in mature virion. After virus attachment to target cell and clathrin-mediated endocytosis, acidification of the endosome would induce dissociation of E1/E2 heterodimer and concomitant trimerization of the E1 subunits (PubMed : 15557740). This E1 homotrimer is fusion active, and promotes release of viral nucleocapsid in cytoplasm after endosome and viral membrane fusion. The cytoplasmic tail of spike glycoprotein E1 modulates virus release. The surface glycoproteins display an irregular helical organization and a pseudo-tetrameric inner nucleocapsid arrangement (By similarity).
Post-translational modifications
Structural polyprotein: Specific enzymatic cleavages in vivo yield mature proteins. Two signal peptidase-mediated cleavages within the polyprotein produce the structural proteins capsid, E2, and E1. The E2 signal peptide remains attached to the C-terminus of the capsid protein after cleavage by the signal peptidase. Another signal peptide at E2 C-terminus directs E1 to the ER, with a similar mechanism.. Spike glycoprotein E1. Contains three N-linked oligosaccharides.. Capsid is phosphorylated on Ser-46 by host. This phosphorylation negatively regulates capsid protein RNA-binding activity (By similarity). Dephosphorylated by human PP1A (By similarity).
Subcellular localisation
Host mitochondrion
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com